Karthik Nagapudi

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
EMORY UNIVERSITY
2
2003
H. LUNDBECK A/S
1
2006
Cytokinetics, Inc.
1
2014
LUNDBECK INC.
1
2006
AMGEN INC.
2
1
2008
2014

Inventor Addresses

AddressDuration
Atlanta, GAJun 10, 04 - Jun 10, 04
SOUTH SAN FRANCISCO, CA, USJan 02, 20 - Dec 12, 24
San Ramon, CA, USJun 01, 23 - Jun 01, 23
Simi Valley, CA, USFeb 12, 09 - Nov 01, 18
South San Francisco, CA, USNov 29, 18 - Feb 11, 25
Woodbridge, NJSep 02, 04 - Oct 23, 08

Technology Profile

Technology Matters
A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE 2
A61K: PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 16
A61P: THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 9

See more…

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
122214172025Salt of omecamtiv mecarbil and process for preparing salt0
2024/0409,5352024SOLID FORMS OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3-FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPROPAN-1-OL AND PROCESSES FOR PREPARING FUSED TRICYCLIC COMPOUNDS COMPRISING A SUBSTITUTED PHENYL OR PYRIDINYL MOIETY, INCLUDING METHODS OF THEIR USE0
2024/0409,5392024PHARMACEUTICAL COMPOUND, SALTS THEREOF, FORMULATION THEREOF, AND METHODS OF MAKING AND USING SAME0
2024/0317,6872024SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SALT2
2024/0317,7382024SOLID FORMS OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3-FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPROPAN-1-OL AND PROCESSES FOR PREPARING FUSED TRICYCLIC COMPOUNDS COMPRISING A SUBSTITUTED PHENYL OR PYRIDINYL MOIETY, INCLUDING METHODS OF THEIR USE0

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.